Anaesthetic gases, refrigerant leaks, medicines and devices, clinical waste. Healthcare emissions sit in places a generic footprint tool never looks, and
Anaesthetic gases and on-site generators are Scope 1, and so are refrigerant leaks from chillers and cold storage. Grid electricity for round-the-clock operation is Scope 2. Medicines, devices, consumables, catering, laundry and patient transport are Scope 3, which is where most of the total sits. Dcycle calculates all three per facility, per legal entity or at group level.
Acute hospitals, outpatient clinics, laboratories, pharmacies and administrative buildings have nothing in common except that they all report to you. Dcycle ingests invoices, smart meter and BMS data per site, applies the grid mix and emission factor that actually belongs to that location, and consolidates upward. Every figure stays traceable to the meter reading or invoice it came from.
Absolute tonnes tell a board nothing about whether a site is improving. Dcycle calculates the intensity metrics healthcare actually manages by: energy per bed day, carbon per admission, water per site, waste per bed day. Benchmark sites against each other, see which ones moved, and take the reduction case to the people who sign off the capex.
Medical supply chains run from active ingredient manufacturers to device makers to the company that washes the linen, and each needs a different question. The supplier portal sends each category the request that fits it, validates responses against recognised factor databases, and shows you coverage by category so you chase the gap that matters rather than every supplier at once.
Volumes by stream, treatment route and licensed carrier, per facility and per period: general and recyclable, clinical and infectious, pharmaceutical and cytotoxic, sharps. The same records that go to the waste regulator feed the diversion rate, the waste-per-bed-day KPI and the ESRS E5 disclosure, instead of being rebuilt by hand for each.
The same data answers a hospital tender's environmental criteria, CSRD and ESRS double materiality with XBRL output, GHG Protocol and ISO 14064 inventories, ISO 14001 and ISO 50001 evidence, EcoVadis and CDP. Collect once, and have the answer ready when a procurement file closes in ten days rather than starting the exercise then.
70–75%
reduction in time-to-report
x3
increase in data coverage
<11 months
to payback
Very little of this arrives as a sustainability report. It arrives as a tender you have to answer, a gas log an inspector asks for, and a charge on what your product leaves in the water. CSRD is the last of them to turn up, and for most of this sector it never does.
Spanish public procurement law requires environmental criteria in tender scoring, and large private groups apply their own. There is no threshold and no grace period: you either have a footprint per product or per service when the file closes, or you score zero on that criterion. This is the obligation that reaches this sector first, and the only one with a deadline someone else sets.
The EU F-gas Regulation phases down HFC supply and requires leak checks, records and certified handling per installation. Hospitals sit on both sides of it: cooling plant across the estate, and inhalation anaesthetics whose warming potential dwarfs almost everything else on a theatre's list. These are Scope 1 emissions that never show up on an energy bill, which is precisely why they get missed.
The recast Urban Wastewater Treatment Directive makes producers of human medicines and cosmetics cover the bulk of the cost of removing micropollutants, through an extended producer responsibility scheme. For a pharma company this is a new cost line tied to what it sells, not a disclosure, and the volumes that determine it are the same ones already in the ERP.
Volumes, treatment route and licensed carrier, per stream and per site, under national and regional waste rules. Most groups already produce these figures for the regulator and then rebuild them by hand for the sustainability report, because the two live in different systems. They are the same numbers.
Large hospital groups and pharmaceutical manufacturers clear this threshold; most clinic networks, laboratories and device suppliers no longer do. For those below it, CSRD still arrives, but as the questionnaire of a customer who is inside scope rather than as a report of their own.
Environmental and human rights risk per supplier and per input, documented. In pharma the awkward part is upstream: active ingredient manufacturing is usually several tiers away and outside the EU, and the structure that answers it is the same supplier portal that collects Scope 3.
Energy manager
1,000+ employees"It is brilliant that the tool works that information and hands you the figure. It is wonderful."
Related solutions
See how Dcycle cuts reporting time by 70%, surfaces operational savings, and gives your auditors what they need, the first time.
See Dcycle in action
